Can Hetrombopag and Eltrombopag be taken together?

Hetrombopag and eltrombopag are both oral, small molecule thrombopoietin receptor agonists (TPO-RA). They bind to the thrombopoietin (TPO) receptor in the human body, initiate a signaling cascade, stimulate the proliferation and differentiation of the bone marrow megakaryocytic system, and thereby promote the production and release of platelets. These two drugs have certain structural similarities. They both contain hydrazide structures and are prone to chelate with metal cations, thus affecting the stability and efficacy of the drugs.

From the perspective of the drug's mechanism of action and clinical use, eltrombopag and eltrombopag can generally be taken alternately. This is because they have similar medicinal effects and are both used to increase platelet counts and treat thrombocytopenia-related diseases. Alternate use of these two drugs can, to a certain extent, avoid side effects or drug resistance that may arise from long-term use of a single drug.

Specifically, there may be differences in how and when you take eltrombopag and eltrombopag. For example, it is generally recommended to take Hetrombopag on an empty stomach and wait 2 hours before eating, and avoid taking it with meals. Eltrombopag is also recommended to be taken on an empty stomach, but it needs to be taken 1 hours before meals or 2 hours after meals. In addition, there are some differences between the two drugs in terms of how they interact with other drugs or foods. Therefore, when using alternately, special attention needs to be paid to the taking time of the drug and its interactions with other drugs or foods.

Although eltrombopag and eltrombopag have similar pharmacological effects, they differ in structure and potential risk of hepatotoxicity. Eltrombopag has a group (biphenyl) that can potentially produce hepatotoxic effects. Although Hetrombopag replaces the biphenyl structure with a furan ring to reduce hepatotoxicity, the furan ring also has the potential risk of hepatotoxicity. Therefore, when using these two drugs for a long time, it is necessary to pay close attention to the patient's liver function and make corresponding monitoring and adjustments as needed.